TrialESMO open2021

Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial.

T K Choueiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.